SLAS Discovery

Papers
(The TQCC of SLAS Discovery is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Outline and background for the EU-OS solubility prediction challenge176
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening70
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery54
Bioassay protocol metadata annotation: Proposed standards adoption54
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei40
Ex vivo discovery of synergistic drug combinations for hematologic malignancies38
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature36
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection26
Protocol for 3D screening of lung cancer spheroids using natural products25
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin24
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay24
Emerging drug discovery ecosystems18
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components18
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling17
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer17
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules16
Role Of Vaccines Against COVID-19 Pandemic16
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern16
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines15
Drug repurposing screen for the rare disease ataxia-telangiectasia15
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis15
Screening for molecular glues – Challenges and opportunities14
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice14
Comparative analysis of antibody-mediated loss-of-function versus gene knock-out and knock-down14
In Memoriam13
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors13
Protocol to develop A 3D tumor model for drug testing applications12
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening12
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicals12
High-Throughput cell-based immunofluorescence assays against influenza11
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells11
Bonferroni’s method, not Tukey’s, should be used to control the total number of false positives when making multiple pairwise comparisons in experiments with few replicates10
Development of a live cell assay for the zinc transporter ZnT810
An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites10
A perspective on the discovery of enzyme activators10
VOC analysis for rapid, early detection of bacteria, mold, and mycoplasma in cell and tissue cultures9
Automated high-throughput, high-content 3D imaging of intact pancreatic islets9
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch9
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc9
A high throughput assay to identify modulators of Death Receptor 3 (DR3)9
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons9
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library9
Publisher's Note9
A robust CETSA data analysis automation workflow for routine screening9
Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders9
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]9
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies9
A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies9
SLAS discovery - special issue - biomolecular condensate drug discovery9
Creating a more strategic small molecule biophysical hit characterization workflow8
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems8
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant8
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models8
Using chemical and biological data to predict drug toxicity8
Characterisation of high throughput screening outputs for small molecule degrader discovery7
High-throughput screening of ALS patient iPSC-derived spinal motor neurons identifies novel compounds that increase neurofilament light chain expression7
WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin7
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes7
Identification of novel inflammasome inhibitors via cellular NLRP3 target engagement assays7
Protocols in drug discovery7
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening7
Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery7
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance7
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models7
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay7
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols7
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase7
1.9440870285034